ONSIZ

Oncobiologics, Inc. Series B Warrant
ONSIZ

Overview Fund Activity
Delisted

ONSIZ was delisted on the 16th of May, 2018.

Back to rankings

13 hedge funds and large institutions have $918K invested in Oncobiologics, Inc. Series B Warrant in 2016 Q2 according to their latest regulatory filings, with 13 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
+13
Holders Change %
–
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PA
Perceptive Advisors
New York
$202K
2
SM
Sabby Management
Florida
$196K
3
CAM
Cormorant Asset Management
Massachusetts
$187K
4
ACA
Avoro Capital Advisors
New York
$105K
5
Marshall Wace
Marshall Wace
United Kingdom
$56K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
PA
1
Perceptive Advisors
New York
$202K +$202K +462,500 New
SM
2
Sabby Management
Florida
$196K +$196K +436,923 New
CAM
3
Cormorant Asset Management
Massachusetts
$187K +$187K +416,666 New
ACA
4
Avoro Capital Advisors
New York
$105K +$105K +233,333 New
Marshall Wace
5
Marshall Wace
United Kingdom
$56K +$56K +125,100 New
PC
6
PointState Capital
New York
$45K +$45K +100,000 New
ACP
7
Acuta Capital Partners
California
$44K +$44K +96,833 New
JG
8
Jefferies Group
New York
$36K +$36K +79,347 New
Millennium Management
9
Millennium Management
New York
$20K +$20K +44,925 New
Hudson Bay Capital Management
10
Hudson Bay Capital Management
Connecticut
$14K +$14K +31,250 New
MIM
11
Monashee Investment Management
Massachusetts
$11K – – –
Morgan Stanley
12
Morgan Stanley
New York
$2K +$2K +5,830 New